摘要
目的:寻找与乳腺癌细胞株间药物敏感性差异相关的基因启动子CpG岛甲基化异常,为DNA甲基化异常作为临床化疗敏感性预测手段提供依据。方法:用MTT法测定3种乳腺癌细胞株(Bcap-37、T47D和ZR-75-30)对9种化疗药物(紫杉醇、紫杉特尔、长春瑞宾、5-氟尿嘧啶(5-FU)、双氟去氧胞苷、表阿霉素、丝裂霉素、依立替康和顺铂)的敏感性;同时用甲基化特异性PCR检测23个基因在3种乳腺癌细胞株中的甲基化状态。结果:受试的3种乳腺癌细胞株仅对5-FU的敏感性有明显差异。其中Bcap-37(IC50:317.386μg/mL)对5-FU相对耐药,而ZR-75-30(IC50:6.676μg/mL)和T47D(IC50:73.076μg/mL)对5-FU相对敏感。23个基因中,有6个基因:ABCC8、CHFR、BMP3B、LOX、PRSS21和RASSF1A在敏感和耐药细胞株中的甲基化状态有差异。其中ABCC8、CHFR和BMP3B在5-FU耐药细胞株中呈相对高甲基化状态,而LOX、PRSS21和RASSF1A则在对5-FU敏感的细胞株中呈相对高甲基化状态。结论:本研究所发现的6个基因的甲基化状态可能与乳腺癌细胞株对5-FU化疗敏感性相关,为下一步进行临床评估和机制探讨提供了依据。
Objective:To identify the abnormal chemosensitivity-associated DNA methylation pattern of CpG islands in the pro- moter region of breast cancer cell lines and provide the evidence for using abnormal DNA methylation in predicting the chemosensitivity in clinic. Methods:The MTT/IC50 assay was used to determine the chemosensifivity of the three breast cancer cell lines ( Beap-37, T47D, and ZR-75-30) to each of the nine anticancer drugs (paclitaxel, docetaxel, vinorelbine, 5-fluorouracil, gemeitabine, epirubiein, mitomycin, ironoteean, and cisplatin). DNA methylation profile of CpG islands in the promoter region of 23 genes of the three breast cancer cell lines was tested by methylafion specific PCR. Results: The sensitivity of the three breast cancer cell lines to 5-FU showed a significant difference. Bcap-37 cells were relatively tolerant to 5-FU (IC50 = 317. 386 μg/mL). ZR-75-30 and T47D were relatively sensitive to 5-FU (ICso = 6. 676 and 73. 076μg/mL, respectively). Out of the 23 genes, the methylation of 6 genes, ABCC8, CHFR, BMP3B, LOX, PRSS21, and RASSF1A, exhibited different patterns between the 5-FU-resistant and sensitive cell lines. The ABCC8, CHFR and BMP3B genes were hypermethylated in the 5-FU-resistant cell line, but LOX, PRSS21, and RASSF1A genes were hypermethylated in the 5-FU-sensitive cell line. Conclusion:There is a promising correlation of the methylation state of 6 genes with the chemosensitivity of the breast cancer cell lines to 5-FU. This study provided the evidence for further clinical evaluation and mechanism exploration.
出处
《肿瘤》
CAS
CSCD
北大核心
2009年第1期20-25,共6页
Tumor
基金
上海市科委资助项目(编号:07DJ14074)
上海市肿瘤医院院外合作项目(编号:YWHZ200601)
关键词
乳腺肿瘤
细胞系
DNA甲基化
抗药性
甲基化特异性聚合酶链反应
Breast neoplasms
Cell lines
DNA nlethylation
Drug resistance
Methylation specific polymerase chain reaction